241 related articles for article (PubMed ID: 31152332)
21. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies.
Schoepfer AM; Trummler M; Seeholzer P; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2008 Jan; 14(1):32-9. PubMed ID: 17924558
[TBL] [Abstract][Full Text] [Related]
22. Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome.
Zhu SW; Liu ZJ; Sun QH; Duan LP
Chin Med J (Engl); 2019 Jul; 132(13):1524-1532. PubMed ID: 31205078
[TBL] [Abstract][Full Text] [Related]
23. Microbiome and Its Role in Irritable Bowel Syndrome.
Pimentel M; Lembo A
Dig Dis Sci; 2020 Mar; 65(3):829-839. PubMed ID: 32026278
[TBL] [Abstract][Full Text] [Related]
24. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
25. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study.
Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM
Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655
[TBL] [Abstract][Full Text] [Related]
27. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
28. The Performance of Nesfatin-1 in Distinguishing Irritable Bowel Syndrome Presenting Predominantly with Diarrhea from Celiac Disease.
Karatay E; Gül-Utku Ö; Aksoy N
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162872
[TBL] [Abstract][Full Text] [Related]
29. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
[TBL] [Abstract][Full Text] [Related]
30. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
31. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
Hod K; Sperber AD; Maharshak N; Ron Y; Shapira I; David Z; Rogowski O; Berliner S; Shenhar-Tsarfaty S; Dekel R
Neurogastroenterol Motil; 2018 Dec; 30(12):e13464. PubMed ID: 30240124
[TBL] [Abstract][Full Text] [Related]
32. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
Szilagyi A; Xue X
Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
[TBL] [Abstract][Full Text] [Related]
33. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
34. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
Du C; Peng L; Kou G; Wang P; Lu L; Li Y
Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
[TBL] [Abstract][Full Text] [Related]
36. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
37. [An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome].
Shi H; Wan J; Liu W; Su B
Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):326-9. PubMed ID: 26268062
[TBL] [Abstract][Full Text] [Related]
38. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
Halpin SJ; Ford AC
Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]